Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2011
06/08/2011CN102085232A Astragalus dispersible tablets
06/08/2011CN102085224A Method for preparing nano-level notoginseng root powder
06/08/2011CN102085205A Medical compound preparation of eugenol aspirin ester and method for preparing same
06/08/2011CN102085204A Pharmaceutical composition for resisting platelet aggregation
06/08/2011CN102085178A Production process for improving stability of enoxaparin sodium injection
06/08/2011CN102084862A Insecticidal composition containing ethiprole
06/08/2011CN101698037B Medicine for treating uterine bleeding and preparation process thereof
06/08/2011CN101679286B Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
06/08/2011CN101549035B Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof
06/08/2011CN101301364B Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof
06/08/2011CN101215549B In vitro reforming method for erythrocyte blood type and special-purpose assorted agent for the same
06/07/2011US7956040 Combination of catechin and quercetin for pharmaceutical or dietary use
06/07/2011CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
06/07/2011CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting
06/03/2011WO2011065444A1 Antithrombotic agent
06/03/2011WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof
06/03/2011WO2011064247A1 Method of purifying pegylated proteins
06/03/2011WO2011063595A1 Depolymerized glycosaminoglycan from thelenota ananas and preparation method thereof
06/03/2011WO2011042918A3 Improved processes for preparing prasugrel and pharmaceutically acceptable salts thereof
06/03/2011WO2011030332A3 Methods for hematopoietic precursor mobilization
06/03/2011WO2011020045A9 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
06/03/2011WO2006119507A3 Non-nucleotide composition and method for inhibiting platelet aggregation
06/02/2011US20110130812 Indwelling heat exchange catheter and method of using same
06/02/2011US20110130445 Substituted 3-phenylpropionic acids and the use thereof
06/02/2011US20110130443 Compositions And Methods For Inhibiting Expression Of Factor V Leiden Mutant Gene
06/02/2011US20110130436 Caspase inhibitors and uses thereof
06/02/2011US20110130432 Heterocyclic Carboxamides For Use As Thrombin Inhibitors
06/02/2011US20110130414 Novel fused thiazolo and oxazolo pyrimidinones
06/02/2011US20110130413 Substituted quinazolines
06/02/2011US20110130405 Substituted quinazolines as blood platelet lowering agents
06/02/2011US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/02/2011US20110130387 Sirtuin modulating compounds
06/02/2011US20110130354 Sulfated oligosaccharide derivatives
06/02/2011US20110130324 Methods for systematic control of protein stability
06/02/2011US20110129883 Inactivation of genes of the mep pathway
06/02/2011US20110129548 Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof
06/02/2011US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof
06/02/2011US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof
06/02/2011US20110129448 Methods to mobilize progenitor/stem cells
06/02/2011US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy
06/02/2011US20110129437 Platelet adhesion-resistant material
06/01/2011EP2326668A1 Anti-il-12/il-23 antibodies
06/01/2011EP2326636A2 Pyrazole carboxamide inhibitors of factor xa
06/01/2011EP2326334A2 Methods for treating bleeding disorders
06/01/2011EP2326332A1 Method for treatment of diseases
06/01/2011EP2326179A1 Prolyl hydroxylase inhibitors
06/01/2011EP2326178A2 Prolyl hydroxylase inhibitors
06/01/2011EP2129378B1 Therapeutic compositions comprising thromboserin or a salt thereof for use in the prevention or treatment of thrombosis in a patient at risk of bleeding
06/01/2011EP1584925B1 Novel screening method
06/01/2011EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole
06/01/2011DE112009000268T5 Prasugrel-Salze mit verbesserten Eigenschaften Prasugrel salts with improved properties
06/01/2011CN1950353B Materials and methods for treating coagulation disorders
06/01/2011CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
06/01/2011CN102083833A Substituted quinazolines as blood platelet lowering agents
06/01/2011CN102083810A Activator for peroxisome proliferator-activated receptor
06/01/2011CN102083787A Vinyl substituted fatty acids
06/01/2011CN102083469A Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates
06/01/2011CN102083443A Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
06/01/2011CN102080117A Inflammatory factor receptor antagonist of microbial source and preparation method thereof
06/01/2011CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof
06/01/2011CN102078603A Medicine with action of treating cardiovascular and cerebrovascular diseases
06/01/2011CN102078589A Marrow-replenishing blood-nourishing pill
06/01/2011CN102078511A Medicine for promoting leukopoiesis
06/01/2011CN102078494A Hemostatic pharmaceutical composition and preparation method thereof
06/01/2011CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor
06/01/2011CN102078479A Saffron crocus dissolved medicine and preparation method thereof
06/01/2011CN102078469A Traditional Chinese medicine composition for treating blood-deficiency type dysmenorrheal
06/01/2011CN102078454A Nano-traditional Chinese medicine preparation for stopping bleeding and easing pain and preparation method thereof
06/01/2011CN102078417A Traditional Chinese medicine fructus sophorae suppository for treating hemorrhoid hematochezia and preparation method thereof
06/01/2011CN102078379A Traditional Chinese medicine pill for treating anemia
06/01/2011CN102078363A Detection method for humifuse euphorbia herb traditional Chinese medicine preparation
06/01/2011CN102078357A Preparation method of Gynura bicolor total flavone extract
06/01/2011CN102078336A Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof
06/01/2011CN102078335A Preparation method of latic acid hirudo liquid
06/01/2011CN102078302A Method for preparing berbamine chitosan-agar nano particles
06/01/2011CN102078300A Solid preparation of Torasemide liposome
06/01/2011CN102078297A Method for preparing osmotic diuretic injection containing high oxygen or electrolyte
06/01/2011CN102078291A Method for preparing iron sorbitex injection
06/01/2011CN102078270A Toothpaste
06/01/2011CN102077901A Swine hemoglobin enzymolysis and decoloration method
06/01/2011CN101810833B Chinese medicinal composition for treating edema and preparation method thereof
06/01/2011CN101757329B Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis
06/01/2011CN101711828B Decoction for promoting blood circulation
06/01/2011CN101624426B Extraction method of holothuria leucospilota glycosaminoglycan
06/01/2011CN101601659B Glutathione enteric-coated pellet and preparation method thereof
06/01/2011CN101492458B Method for preparation of hydronol with tetravalent metal phosphate as catalyst
06/01/2011CN101421242B Dicarboxamide derivatives
05/2011
05/31/2011US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/31/2011US7951356 Tissue factor compositions and kits for coagulation and tumor treatment
05/31/2011CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
05/31/2011CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use
05/31/2011CA2398539C Myeloid colony stimulating factor and uses thereof
05/26/2011WO2011062436A2 Composition for improving blood circulation, containing extract of lindera obtusiloba as active ingredient
05/26/2011WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011WO2011061760A1 Novel antithrombotic agents
05/26/2011WO2011061271A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
05/26/2011WO2011060583A1 Nonnatural collagen-like protein and use thereof
05/26/2011US20110126303 Modified Blood Clotting Factors And Methods Of Use
05/26/2011US20110125237 Indwelling heat exchange catheter and method of using same
05/26/2011US20110125236 Indwelling heat exchange catheter and method of using same